COMPETITIVE INTELLIGENCE IN AN AGILE WORLD

June 9, 2019

This thought piece explores the concept of agile working for the pharma world, delving into the opportunities and challenges that arise for CI teams and managers as working environments adapt to find success in a more dynamic, uncertain, and fast-paced environment.

Spotlight

Biolab Sanus Farmaceutica

Biolab is one of the 10 largest pharmaceutical companies in Brazil. The main characteristics about the trajectory is based on the commitment to offer health and quality of life to the Brazilian population. It is a market leader in Cardiology medicine prescriptions, vice-leader in the segment of Gynecology and acts with relevance in the areas of Dermatology, Orthopedics, Rheumatology and Pediatrics. With a portfolio of more than 100 products, Biolab has one of the most modern Research, Development and Innovation (R&D) Centers in Brazil and is growing as a result of partnerships with universities and national and international research laboratories, as well as commitment with actions of social responsibility and support to Brazilian culture.

OTHER WHITEPAPERS
news image

Effects Of X-Ray Inspection On Pharmaceutical Products

whitePaper | December 12, 2019

X-ray inspection of pharmaceutical products and over-the-counter (OTC) medications are steadily increasing in use as pharmaceutical manufacturers worldwide strive to safeguard their brand reputations, protect consumers' welfare and comply with national and international regulations and legislation.

Read More
news image

Coronavirus (COVID-19) and Its Effect on Pharmaceutical Marketing and Sales

whitePaper | March 16, 2020

With the rapid onset of coronavirus in the United States, many pharma companies are being forced to prepare for a scenario in which their reps cannot visit providers and patients are limited in their ability to visit their healthcare professionals (HCP). The CDC has gone as far as recommending the use of telemedicine and patient portals as primary channels for HCPs and patients to interact.

Read More
news image

Application Notes & Whitepapers 2019

whitePaper | December 19, 2019

Welcome to European Pharmaceutical Review’s Application Notes & Whitepapers Supplement 2019. This year’s topics range from analytical techniques for bioprocess investigation, host cell protein analysis and Raman imaging to advice on outsourcing services for product characterisation.

Read More
news image

Deck 7 Webinars and Virtual Events

whitePaper | January 1, 2020

If you recognize some of these challenges, download the Deck 7 Webinar & Virtual Events overview to see how we make it easy for busy marketers to run highly successful webinars and virtual events....

Read More
news image

Research and Development in the Pharmaceutical Industry

whitePaper | April 1, 2021

Every year, the U.S. pharmaceutical industry develops a variety of new drugs that provide valuable medical benefits. Many of those drugs are expensive and contribute to rising health care costs for the private sector and the federal government. Policymakers have considered policies that would lower drug prices and reduce federal drug expenditures. Such policies would probably reduce the industry’s incentive to develop new drugs.

Read More
news image

A Vision for the Global Generic and Biosimilar Medicines Industry

whitePaper | May 22, 2021

One of the key roles of the generic and biosimilar medicines industry is specifically to promote the widest possible access to affordable medicines with high quality, safety, and efficacy for patients globally by introducing competition into the markets. Despite the many hurdles, the generic medicines companies have clearly lived up to the challenges posed by the pandemic as it is an industry that is quick to adapt and agile in manufacturing scale-up. During the outbreak of COVID-19, this industry was providing most of the medicines needed in Intensive Care Units to ventilate critically ill COVID patients. It is also providing most of the quality medicines dispensed around the world, especially for increasingly prevalent chronic diseases and is therefore a strong contributor to health outcomes globally.

Read More

Spotlight

Biolab Sanus Farmaceutica

Biolab is one of the 10 largest pharmaceutical companies in Brazil. The main characteristics about the trajectory is based on the commitment to offer health and quality of life to the Brazilian population. It is a market leader in Cardiology medicine prescriptions, vice-leader in the segment of Gynecology and acts with relevance in the areas of Dermatology, Orthopedics, Rheumatology and Pediatrics. With a portfolio of more than 100 products, Biolab has one of the most modern Research, Development and Innovation (R&D) Centers in Brazil and is growing as a result of partnerships with universities and national and international research laboratories, as well as commitment with actions of social responsibility and support to Brazilian culture.

Events